awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26799467-8820131C-1B8B-4BB0-AFCF-11E2C808887F
Q26799467-8820131C-1B8B-4BB0-AFCF-11E2C808887F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26799467-8820131C-1B8B-4BB0-AFCF-11E2C808887F
Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough
P2860
Q26799467-8820131C-1B8B-4BB0-AFCF-11E2C808887F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26799467-8820131C-1B8B-4BB0-AFCF-11E2C808887F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8cec7da0358c8a01e180494238bda4217cfe5262
P2860
Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas.